Psychedelics Today
In this episode, Joe Moore sits down with Dr. Jason Konner, a longtime oncologist who recently left his full-time clinical role at to devote himself to the emerging intersection of cancer care and psychedelics. Dr Konner shares how, after more than two decades treating people, he hit a wall. The accumulated grief, constant exposure to death, and intensity of oncology left him deeply , though he didn’t have that language for it at the time. A chance moment in a yoga class, overhearing someone say “ retreat” just before he was scheduled for hernia surgery, became the turning point....
info_outlinePsychedelics Today
Clinical psychologist Dr. Genesee Herzberg joins Kyle to reflect on two decades in trauma work and 15 years inside the psychedelic ecosystem—from early MAPS conferences to running Sage Integrative Health. She traces how personal psychedelic experiences set her on a path of service, research at CIIS on MDMA-assisted therapy, and hands-on roles with MAPS: Zendo Project harm reduction, adherence rating, and ultimately serving as an MDMA therapist in clinical trials. Today she leads Sage, an integrative clinic (psychotherapy, psychiatry, bodywork, acupuncture, and functional nutrition) focused...
info_outlinePsychedelics Today
Clinical psychologist joins to share insights from her decade of work with and her evolving focus on community-based integration. As the former Clinical Lead for , Dr. Watts witnessed how psychedelic experiences can foster profound feelings of — to self, others, and nature — yet also how that connection can fade without ongoing support. In this conversation, she reflects on what years of research have taught her about connectedness as both a healing mechanism and a human need. She explores how can transform fleeting psychedelic breakthroughs into lasting change, and why community is...
info_outlinePsychedelics Today
Artist, builder, and podcast host Jennifer Espenscheid joins Joe Moore for a rich conversation on creativity, process, and the spiritual dimensions of making art. Drawing from her South Dakota roots and large-scale works like Luciferia, Jennifer reflects on the blend of grit, intuition, and trust that guides her artistic life. She discusses how psychedelics have served as a tool for clarity and healing rather than direct creation of art, helping her dissolve patterns and reconnect to innate creativity. They explore how events like Burning Man catalyze inspiration, why intention and...
info_outlinePsychedelics Today
Brad Adams — LAMPS (Los Angeles Psychedelic Society) joins Kyle to trace his path from PhD researcher to community builder. Brad shares how early work in AIDS, Alzheimer’s, gerontology, and cancer research primed him to notice Harbor-UCLA’s psilocybin pilot for stage-4 cancer patients with death anxiety—where the strongest mystical experiences correlated with profound death acceptance. Teaming with Dennis McKenna, he ran an ayahuasca pilot in Peru and presented findings at Psychedelic Science 2017. From there, Brad founded LAMPS: first as research meetups at UCLA, then as a thriving...
info_outlinePsychedelics Today
In this episode, Kyle and Joe sit down with filmmaker Mustapha Khan and Dreamshadow’s Elizabeth & Lenny Gibson to explore Life and Breath—a new documentary immersing viewers in the experience and community of Holotropic Breathwork. We talk about why Mustapha was drawn to Dreamshadow, the film’s cinéma vérité approach that places you “in the room,” and how years of facilitation informed what became both an archival record and a living portrait of transformation. Elizabeth and Lenny reflect on 35+ years of holding space, the role of curiosity over agenda, and why genuine...
info_outlinePsychedelics Today
In this episode, Joe Moore talks with Megan Portnoy, a doctoral candidate in clinical psychology at Antioch University New England, about how can reshape the environments used in psychedelic-assisted therapy. Megan explains how physical space is not just a backdrop but an active participant in the therapeutic process, influencing emotion, cognition, and healing. She recently for her presentation on this topic at . They explore how design principles that foster awe, play, and flexibility can deepen integration and expand what’s possible in clinical settings. The conversation also...
info_outlinePsychedelics Today
Joe and Kyle open with reflections from their first r/psychonaut AMA, then pivot to why they’re building Navigators—our off-social community with book/film clubs, early ad-free episodes, mentorship, and an expanding education library. The core discussion explores touch and bodywork in breathwork and psychedelic contexts: why defaulting to “no touch” and moving slowly matters; informed consent; reading nonverbals; and keeping client agency central. They unpack trauma-informed concepts like the window of tolerance, polyvagal‐adjacent ideas (and critiques), and the ethics of avoiding...
info_outlinePsychedelics Today
Interviewers: Joe Moore & Anne Philippi Guests: TK Wonder & Cipriana Quann (The Quann Sisters) Recorded: June 18 during MAPS PS 2025 Content note: This episode discusses childhood sexual, physical, and emotional abuse, suicidal ideation, disordered eating, and recovery. Identical twins, writers, and culture-shapers TK Wonder and Cipriana Quann join Joe and Anne for a frank, generous conversation about identity, resilience, and the long arc of healing. Cipriana recounts launching Urban Bush Babes in 2011 to center women of color in beauty and fashion—work that led to a Vogue...
info_outlinePsychedelics Today
In this candid, practice-focused conversation, Joe is joined by Norwegian psychologist and researcher to explore how therapists’ own healing journeys can measurably improve client outcomes—and why MDMA-assisted experiences, used thoughtfully, may be a uniquely powerful catalyst for professional development. Ivar shares lessons from Norway’s psychedelic research team (PTSD and the world’s first MDMA-for-depression trial), his clinic in Oslo, and his , “,” which uses authentic footage from his FDA-approved MAPS volunteer MDMA sessions to illuminate real clinical processes,...
info_outlineIn this episode, Joe Moore sits down with Dr. Jason Konner, a longtime oncologist who recently left his full-time clinical role at Memorial Sloan Kettering to devote himself to the emerging intersection of cancer care and psychedelics.
Dr Konner shares how, after more than two decades treating people, he hit a wall. The accumulated grief, constant exposure to death, and intensity of oncology left him deeply burned out, though he didn’t have that language for it at the time. A chance moment in a yoga class, overhearing someone say “ayahuasca retreat” just before he was scheduled for hernia surgery, became the turning point. Within a week, he was in the jungle.
That first week with ayahuasca, followed later by work with mushrooms, “absolutely transformed” his life. His fear of death lifted. The burnout he hadn’t even recognized in himself was both revealed and relieved. When he returned to his practice, Konner describes feeling like he suddenly had a “superpower”: he could stay present, connected, and compassionate with patients facing advanced disease without collapsing under the emotional weight.
He and Joe explore what this third path looks like: not the classic binary between either hardening and distancing as self-protection, or staying open-hearted and getting shattered. Instead, psychedelics helped him hold deep relationship with patients and families while maintaining inner stability and meaning. This opened space for authentic conversations about spirituality, fear, grief, and what it means to live with (or die from) cancer.
From there, Dr Konner zooms out to critique the broader oncology system:
- The lack of training and support for oncologists around their own emotional and existential load,
- How little space there is for relational work even though it’s central to healing,
- Why many support groups and standard psychiatric approaches (like reflexively prescribing SSRIs) often miss the mark for people dealing with cancer,
- How caregivers, partners, family members, and others are deeply affected but rarely truly supported.
Joe and Jason then dig into psychedelics and oncology as a frontier: easing existential distress in patients with terminal cancer, the neglected suffering of caregivers, the potential role of psychedelics in helping people relate differently to death, and what it might mean for ICU use, aggressive end-of-life interventions, and overall healthcare costs if more people could make decisions from a place of peace rather than terror.
Dr Konner also shares a striking ovarian cancer case that hinted at powerful immune changes after shamanic work, and why he believes we need new research paradigms that can honor the integrity of retreat and ceremonial settings while still learning from them.
Finally, he talks about his early-stage project, Psychedelic Oncology, and his hope that the first wave of change starts with clinicians themselves becoming more psychedelic-literate—and, where appropriate, doing their own inner work—so better options can eventually reach the people who need them most.